Pyxis Oncology Successfully Completes Acquisition of Apexigen

Go back to Pyxis Oncology Successfully Completes Acquisition of Apexigen
(NASDAQ: PYXS) Delayed: 1.69 +0.01 (0.60%)
Previous Close $1.68    52 Week High $ 
Open $1.66    52 Week Low $ 
Day High $1.72    P/E N/A 
Day Low $1.63    EPS $ 
Volume 645,784